Edwards Lifesciences Corp (NYSE:EW)

135.95
Delayed Data
As of 4:01pm ET
 -1.62 / -1.18%
Today’s Change
100.20
Today|||52-Week Range
143.22
+20.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line811.1M494.9M569.5M583.6M
 
 
 
 
 
Depreciation68.6M65.8M71.2M81.9M
 
 
 
 
 
Total Other Cash Flow23.4M19.6M35.0M83.2M
 
 
 
 
 
Funds From Operations832.0M485.3M638.3M766.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-190.3M-64.4M-66.1M-234.2M
 
 
 
 
 
Net Cash Flow - Operating Activities1.0B549.7M704.4M1.0B
 
 
 
 
 
 
InvestingIncrease In Investments-2.1B-1.3B-1.1B-1.3B
 
 
 
 
 
Decrease In Investments1.6B1.4B1.1B1.1B
 
 
 
 
 
Capital Expenditures-82.9M-102.7M-176.1M-168.1M
 
 
 
 
 
Fixed Asset Disposal3.1M2.4M----
 
 
 
Net Assets From Acquisitions -15.0M-331.6M0.00-192.9M
 
 
 
 
Other Investing - Uses-10.8M0.00-1.2M-43.9M
 
 
 
 
Other Investing - Sources--0.002.4M800.0K
 
 
 
Net Cash Flow Investing-633.0M-316.1M-211.7M-647.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings226.3M31.4M253.5M994.7M
 
 
 
 
 
Long Term Debt Reduction-239.0M-29.5M-31.4M-818.4M
 
 
 
 
 
Net Proceeds Stock Sale113.3M87.2M103.3M113.8M
 
 
 
 
 
Common Preferred Redeemed-300.9M-280.1M-662.3M-763.3M
 
 
 
 
 
Common Dividends0.000.00------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing49.4M41.3M68.4M0.00
 
 
 
 
Other Uses - Financing2.1M8.9M--0.00
 
 
 
Net Cash Flow - Financing-153.0M-158.6M-268.5M-473.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-2.9M-10.4M-12.5M7.9M
 
 
 
 
 
 
Net Change In Cash236.3M75.0M224.2M-119.7M